Invention Grant
- Patent Title: Treatment of hepatic encephalopathy and liver cirrhosis
-
Application No.: US13162160Application Date: 2011-06-16
-
Publication No.: US10166202B2Publication Date: 2019-01-01
- Inventor: Elliot Berry , Yosefa Avraham , Raphael Mechoulam , Yaron Ilan , Yossi Dagon , Iddo Magen , Nicholas Grigoriadis , Theofilos Poutachidis
- Applicant: Elliot Berry , Yosefa Avraham , Raphael Mechoulam , Yaron Ilan , Yossi Dagon , Iddo Magen , Nicholas Grigoriadis , Theofilos Poutachidis
- Applicant Address: IL Jerusalem IL Jerusalem GR Thessaloniki
- Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem,Hadasit Medical Research Services & Development Ltd.,Aristotle University of Thessaloniki
- Current Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem,Hadasit Medical Research Services & Development Ltd.,Aristotle University of Thessaloniki
- Current Assignee Address: IL Jerusalem IL Jerusalem GR Thessaloniki
- Agency: Browdy and Neimark, PLLC
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61K31/09 ; A61K31/165 ; A61K31/232 ; A61K31/352
Abstract:
The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.
Public/Granted literature
- US20110251290A1 TREATMENT OF HEPATIC ENCEPHALOPATHY AND LIVER CIRRHOSIS Public/Granted day:2011-10-13
Information query
